These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 5537078)

  • 21. Synthesis of fluorinated brassinosteroids based on alkene cross-metathesis and preliminary biological assessment.
    Eignerová B; Slavíková B; Budĕsínský M; Dracínský M; Klepetárová B; St'astná E; Kotora M
    J Med Chem; 2009 Sep; 52(18):5753-7. PubMed ID: 19719120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1-[(omega-aminoalkyl)amino]-4-[N-(omega-aminoalkyl)carbamoyl]-9-oxo-9, 10-dihydroacridines as intercalating cytotoxic agents: synthesis, DNA binding, and biological evaluation.
    Antonini I; Polucci P; Jenkins TC; Kelland LR; Menta E; Pescalli N; Stefanska B; Mazerski J; Martelli S
    J Med Chem; 1997 Nov; 40(23):3749-55. PubMed ID: 9371240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological aspects of the subrenal capsule assay of importance in the screening of cytostatic agents.
    Edelstein MB; Smink T; van Putten LM
    Behring Inst Mitt; 1984 May; (74):285-90. PubMed ID: 6477357
    [No Abstract]   [Full Text] [Related]  

  • 24. A modified screening system to select new cytostatic drugs.
    Kraemer HP; Sedlacek HH
    Behring Inst Mitt; 1984 May; (74):301-28. PubMed ID: 6383326
    [No Abstract]   [Full Text] [Related]  

  • 25. Hypoxia-inducible factor 1 inhibitors.
    Melillo G
    Methods Enzymol; 2007; 435():385-402. PubMed ID: 17998065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An in vitro transcription assay for probing drug-DNA interactions during active transcription of DNA.
    Phillips DR; Crothers DM
    Methods Mol Biol; 1995; 37():89-105. PubMed ID: 7540091
    [No Abstract]   [Full Text] [Related]  

  • 27. [On the pharmacology of aziprine].
    Ponomareva AG
    Farmakol Toksikol; 1969; 32(3):316-8. PubMed ID: 5810950
    [No Abstract]   [Full Text] [Related]  

  • 28. Rationale and practice of testing chemotherapeutic agents for prostate cancer.
    Sandberg AA
    Urology; 1981 Apr; 17(4 Suppl):34-44. PubMed ID: 7210392
    [No Abstract]   [Full Text] [Related]  

  • 29. Design, synthesis, and anti-tumor evaluation of novel symmetrical bis-benzimidazoles.
    Yang YH; Cheng MS; Wang QH; Nie H; Liao N; Wang J; Chen H
    Eur J Med Chem; 2009 Apr; 44(4):1808-12. PubMed ID: 18762358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The quinobenzoxazines: relationship between DNA binding and biological activity.
    Kwok Y; Sun D; Clement JJ; Hurley LH
    Anticancer Drug Des; 1999 Oct; 14(5):443-50. PubMed ID: 10766299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new in vitro assay for anticancer compounds and a biochemical assay for their effect on metabolic cooperation.
    Vitkauskas G; Pawlak K; Canellakis ES
    Prog Clin Biol Res; 1982; 102 pt A():457-74. PubMed ID: 7167451
    [No Abstract]   [Full Text] [Related]  

  • 32. SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 1: cellular pharmacology, in vitro and initial in vivo antitumor activity.
    Hartley JA; Spanswick VJ; Brooks N; Clingen PH; McHugh PJ; Hochhauser D; Pedley RB; Kelland LR; Alley MC; Schultz R; Hollingshead MG; Schweikart KM; Tomaszewski JE; Sausville EA; Gregson SJ; Howard PW; Thurston DE
    Cancer Res; 2004 Sep; 64(18):6693-9. PubMed ID: 15374986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA adducts of N-nitrosoureas.
    Eisenbrand G; Pfeiffer C; Tang W
    IARC Sci Publ; 1994; (125):277-93. PubMed ID: 7806318
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of vinca alkaloid anticancer drug, vinorelbine, on chromatin and histone proteins in solution.
    Rabbani-Chadegani A; Chamani E; Hajihassan Z
    Eur J Pharmacol; 2009 Jun; 613(1-3):34-8. PubMed ID: 19394329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The evaluation of developmental toxicity of chemicals exposed occupationally using whole embryo culture.
    Zhao SF; Zhang XC; Zhang LF; Zhou SS; Zhang F; Wang QF; Wang YL; Bao YS
    Int J Dev Biol; 1997 Apr; 41(2):275-82. PubMed ID: 9184335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative pharmacology of the novel cyclopropylpyrroloindole-prodrug carzelesin in mice, rats, and humans.
    van Tellingen O; Nooijen WJ; Schaaf LJ; van der Valk M; van Asperen J; Henrar RE; Beijnen JH
    Cancer Res; 1998 Jun; 58(11):2410-6. PubMed ID: 9622082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Sunrabin for injection].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):2077-81. PubMed ID: 6614941
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition of DNA synthesis in HeLa cells by hydroxyurea.
    Pfeiffer SE; Tolmach LJ
    Cancer Res; 1967 Jan; 27(1):124-9. PubMed ID: 6020353
    [No Abstract]   [Full Text] [Related]  

  • 39. [Evaluation of the effect of antineoplastic drugs in tissue cultures].
    Timofeevskaia EA
    Vestn Akad Med Nauk SSSR; 1966; 21(9):70-7. PubMed ID: 4874529
    [No Abstract]   [Full Text] [Related]  

  • 40. Pyrimido [4,5,6-kl] acridines, a new class of potential anticancer agents. Synthesis and biological evaluation.
    Antonini I; Polucci P; Cola D; Bontemps-Gracz M; Pescalli N; Menta E; Martelli S
    Anticancer Drug Des; 1996 Jun; 11(4):339-49. PubMed ID: 8679056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.